Into an area that big pharma chose to abandon, a non-profit braves its way.The world of pharma has had a checkered history. Over the past 20 years, more than 30 new human diseases have emerged. How-ever, modern science has made both cure and prevention possible. Easy ac-cess to an array of effective drugs and vaccines has brought about a drastic change in health figures across the globe. But, this success hides a gray area—that of the third world where killer diseases still threaten the lives of the poor. Infectious diseases now account for only one out of 10 deaths in the developed countries. Yet among the poor, 6 in 10 still die of infectious diseases, according to the World Health Organization (WHO).

According to the Global Forum for Health Research, every year more than $70 bn are spent worldwide on health research and development by the public and private sectors. But, only a measly 10% of this is allotted for research in health problems of the third world. The consequences of this disparity are visible across the globe.

OneWorld Health,Drugs for the Poor,health, research, pharma, change, development, history, killer, infectious, Organization, public, problems, private, vaccines,Health Research,World Health Organization.